GS-5745 Active Not Recruiting Phase 1 Trials for Gastric Adenocarcinoma / Adenocarcinomas of the Gastroesophageal Junction Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02862535Andecaliximab as Monotherapy and in Combination With Anti-Cancer Agents in Japanese Participants With Gastric or Gastroesophageal Junction Adenocarcinoma